bromazepam ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
diazepam derivatives 399 1812-30-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • bromazepam
  • durazanil
One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS.
  • Molecular weight: 316.16
  • Formula: C14H10BrN3O
  • CLOGP: 1.70
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 1
  • TPSA: 54.35
  • ALOGS: -3.90
  • ROTB: 1

Drug dosage:

DoseUnitRoute
10 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.03 mg/mL Bocci G, Oprea TI, Benet LZ
MRTD (Maximum Recommended Therapeutic Daily Dose) 1.36 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 84 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution) 0.85 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 0.51 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.48 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 21 hours Lombardo F, Berellini G, Obach RS

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 2.048 Moderate 0.65
caco2-efflux Caco-2 efflux ratio (BA/AB) 0.705 Moderate 0.65
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 77.446 10^-6 cm/s Moderate 0.65
dh-clint Dog hepatocyte intrinsic clearance 24.044 uL/min/10^6 cells Moderate 0.65
dppb Dog plasma protein binding (% unbound) 21.990 % Moderate 0.65
fcs-ppb Fetal calf serum protein binding (% unbound) 40.890 % Moderate 0.65
herg hERG pIC50 4.152 pIC50 Moderate 0.65
hh-clint Human hepatocyte intrinsic clearance 3.936 uL/min/10^6 cells Moderate 0.65
hlm-clint Human liver microsomal intrinsic clearance 12.359 uL/min/mg protein Moderate 0.65
hppb Human plasma protein binding (% unbound) 30.780 % Moderate 0.65
kinase-safety-class EIF2AK3,GRK2,PDK1,PDK2,PDK4 5
kinase-selectivity-class GRK2 1
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 1.012 Moderate 0.65
mh-clint Mouse hepatocyte intrinsic clearance 19.055 Moderate 0.65
mppb Mouse plasma protein binding (% unbound) 29.950 Moderate 0.65
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 0.912 Moderate 0.65
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 32.770 % Moderate 0.65
rh-clint Rat hepatocyte intrinsic clearance 19.770 uL/min/10^6 cells Moderate 0.65
rh-fuinc Rat hepatocyte fraction unbound in incubation 85.340 % Moderate 0.65
rppb Rat plasma protein binding (% unbound) 29.330 % Moderate 0.65
solubility-dd Solubility at pH 7.4 in DMSO 193.642 uM Moderate 0.65

Approvals:

DateAgencyCompanyOrphan
Jan. 1, 1974 YEAR INTRODUCED

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Coma 1003.56 17.05 450 22909 72182 90532906
Drug abuse 955.68 17.05 452 22907 81895 90523193
Poisoning deliberate 757.92 17.05 246 23113 16240 90588848
Drug use disorder 650.93 17.05 187 23172 8156 90596932
Sopor 545.97 17.05 214 23145 24430 90580658
Toxicity to various agents 495.86 17.05 481 22878 287365 90317723
Intentional overdose 438.72 17.05 283 23076 93551 90511537
Somnolence 381.52 17.05 361 22998 208723 90396365
Suicide attempt 351.31 17.05 227 23132 75172 90529916
Drug interaction 257.85 17.05 336 23023 276117 90328971
Hypotension 241.22 17.05 354 23005 325043 90280045
Altered state of consciousness 211.47 17.05 120 23239 31412 90573676
Miosis 208.64 17.05 82 23277 9402 90595686
Mydriasis 197.24 17.05 90 23269 14922 90590166
Bradypnoea 187.78 17.05 63 23296 4595 90600493
Drug dependence 181.68 17.05 106 23253 29221 90575867
Hyponatraemia 172.98 17.05 192 23167 133346 90471742
Poisoning 171.34 17.05 82 23277 15135 90589953
Overdose 171.19 17.05 207 23152 157502 90447586
Hypothermia 163.51 17.05 80 23279 15495 90589593
Bradycardia 149.15 17.05 143 23216 83704 90521384
Fall 143.21 17.05 355 23004 481455 90123633
Intentional product misuse 141.13 17.05 143 23216 89461 90515627
Electrocardiogram QT prolonged 137.31 17.05 128 23231 72328 90532760
Hepatocellular injury 136.72 17.05 88 23271 28870 90576218
Respiratory acidosis 126.94 17.05 55 23304 8064 90597024
Substance use disorder 125.58 17.05 38 23321 1982 90603106
Hypokalaemia 122.92 17.05 160 23199 130956 90474132
Prescription form tampering 122.48 17.05 30 23329 697 90604391
Parkinsonism 103.73 17.05 57 23302 14008 90591080
Pneumonia aspiration 100.93 17.05 84 23275 40856 90564232
Depressed level of consciousness 99.98 17.05 108 23251 72676 90532412
Joint swelling 99.75 17.05 8 23351 503292 90101796
Bradyphrenia 94.85 17.05 44 23315 7568 90597520
Confusional state 93.62 17.05 264 23095 385941 90219147
Acute kidney injury 91.76 17.05 233 23126 320154 90284934
Toxic epidermal necrolysis 91.30 17.05 72 23287 32456 90572632
Abdominal discomfort 90.77 17.05 9 23350 477319 90127769
Pain 88.97 17.05 76 23283 996265 89608823
Intentional self-injury 86.81 17.05 67 23292 29267 90575821
Asphyxia 82.16 17.05 39 23320 7064 90598024
Infusion related reaction 81.52 17.05 7 23352 416773 90188315
Systemic lupus erythematosus 80.14 17.05 3 23356 361893 90243195
Toxic skin eruption 79.58 17.05 50 23309 15724 90589364
Extrapyramidal disorder 78.07 17.05 50 23309 16253 90588835
Arthropathy 77.93 17.05 4 23355 366238 90238850
Metabolic acidosis 77.12 17.05 83 23276 55593 90549495
Suicidal ideation 75.27 17.05 94 23265 73761 90531327
Hyperthermia 73.78 17.05 41 23318 10294 90594794
Peripheral swelling 73.02 17.05 10 23349 413096 90191992
Drug ineffective 70.95 17.05 158 23201 1384140 89220948
Hypoglycaemia 69.75 17.05 88 23271 69760 90535328
Drug hypersensitivity 69.57 17.05 17 23342 463592 90141496
Psychomotor hyperactivity 68.14 17.05 42 23317 12771 90592317
Persecutory delusion 67.96 17.05 27 23332 3181 90601907
Respiratory depression 67.81 17.05 45 23314 15530 90589558
Alopecia 67.17 17.05 22 23337 495049 90110039
Nasopharyngitis 67.09 17.05 12 23347 407092 90197996
Rhabdomyolysis 66.79 17.05 74 23285 51182 90553906
Agitation 66.15 17.05 84 23275 67014 90538074
Treatment failure 65.67 17.05 3 23356 303925 90301163
Accidental death 64.35 17.05 23 23336 2025 90603063
Cor pulmonale acute 63.06 17.05 16 23343 431 90604657
Tremor 62.21 17.05 128 23231 153045 90452043
Swelling 61.64 17.05 16 23343 419042 90186046
Rheumatoid arthritis 61.26 17.05 10 23349 362604 90242484
Drug intolerance 60.51 17.05 20 23339 447571 90157517
Arrhythmia 60.20 17.05 64 23295 42268 90562820
Therapeutic product effect decreased 59.13 17.05 3 23356 277568 90327520
Hepatitis acute 58.69 17.05 36 23323 10851 90594237
Contraindicated product administered 58.37 17.05 7 23352 320132 90284956
Vertigo 57.44 17.05 80 23279 69731 90535357
Inappropriate antidiuretic hormone secretion 56.51 17.05 44 23315 19461 90585627
Sinusitis 54.63 17.05 11 23348 343077 90262011
Disorientation 54.59 17.05 62 23297 44052 90561036
Disturbance in attention 54.58 17.05 64 23295 47045 90558043
Bezoar 54.42 17.05 22 23337 2712 90602376
Pericarditis 54.30 17.05 4 23355 270147 90334941
Bradykinesia 54.20 17.05 29 23330 6759 90598329
Coma scale abnormal 53.42 17.05 27 23332 5599 90599489
Psychomotor skills impaired 53.37 17.05 22 23337 2850 90602238
Loss of consciousness 53.22 17.05 114 23245 140124 90464964
Withdrawal syndrome 52.99 17.05 45 23314 22479 90582609
Dermatitis exfoliative 50.91 17.05 26 23333 5510 90599578
Hepatic enzyme increased 50.74 17.05 15 23344 360721 90244367
Rash 50.18 17.05 80 23279 796020 89809068
Wrong rate 49.51 17.05 11 23348 164 90604924
Livedo reticularis 49.43 17.05 22 23337 3437 90601651
Wheezing 49.38 17.05 3 23356 238077 90367011
Arthralgia 49.28 17.05 78 23281 778444 89826644
Labelled drug-drug interaction issue 47.82 17.05 19 23340 2239 90602849
Wound 47.64 17.05 10 23349 302970 90302118
Product dose omission issue 47.17 17.05 9 23350 291678 90313410
Vasoplegia syndrome 47.07 17.05 20 23339 2794 90602294
Lower respiratory tract infection 46.89 17.05 5 23354 250654 90354434
Hypersensitivity 45.13 17.05 31 23328 454646 90150442
Serotonin syndrome 44.77 17.05 52 23307 37835 90567253
Hypercapnic coma 44.65 17.05 11 23348 262 90604826
Electrocardiogram QRS complex prolonged 44.01 17.05 26 23333 7322 90597766
Salivary hypersecretion 43.81 17.05 28 23331 9064 90596024
Cholestasis 43.19 17.05 50 23309 36249 90568839
Cholinergic syndrome 42.86 17.05 13 23346 683 90604405
Sinus tachycardia 42.12 17.05 44 23315 28469 90576619
Autoimmune haemolytic anaemia 41.96 17.05 23 23336 5622 90599466
Lactic acidosis 41.76 17.05 58 23301 50405 90554683
Meningioma 41.43 17.05 22 23337 5049 90600039
Postmortem blood drug level abnormal 40.43 17.05 10 23349 242 90604846
Cardiogenic shock 40.22 17.05 40 23319 24428 90580660
Contusion 40.09 17.05 8 23351 251208 90353880
Agranulocytosis 39.63 17.05 47 23312 34955 90570133
Irritable bowel syndrome 39.15 17.05 4 23355 207444 90397644
Leukocytosis 39.09 17.05 44 23315 30946 90574142
Hepatitis toxic 38.69 17.05 19 23340 3706 90601382
Sinoatrial block 38.17 17.05 13 23346 992 90604096
Thymus disorder 37.76 17.05 10 23349 320 90604768
Blood cholesterol increased 36.80 17.05 5 23354 208007 90397081
Impaired healing 36.26 17.05 8 23351 234191 90370897
Myoglobin blood increased 36.18 17.05 14 23345 1538 90603550
Sinus bradycardia 36.10 17.05 32 23327 16920 90588168
Drug level increased 36.02 17.05 40 23319 27722 90577366
Hepatic cytolysis 35.81 17.05 42 23317 30874 90574214
Housebound 35.66 17.05 9 23350 237 90604851
Infection 35.50 17.05 25 23334 362069 90243019
Muscle injury 34.41 17.05 3 23356 176651 90428437
Mobility decreased 34.21 17.05 11 23348 250723 90354365
Ventricular dyskinesia 34.19 17.05 8 23351 152 90604936
Cross sensitivity reaction 34.00 17.05 16 23343 2841 90602247
Hyperthyroidism 33.99 17.05 32 23327 18278 90586810
Musculoskeletal stiffness 33.95 17.05 17 23342 296515 90308573
Psychiatric decompensation 33.13 17.05 14 23345 1929 90603159
Pyramidal tract syndrome 32.55 17.05 10 23349 549 90604539
Alcohol abuse 32.52 17.05 14 23345 2019 90603069
Bronchospasm 32.47 17.05 33 23326 20676 90584412
Drug reaction with eosinophilia and systemic symptoms 32.22 17.05 47 23312 42711 90562377
Prevertebral soft tissue swelling of cervical space 31.92 17.05 6 23353 36 90605052
Osteoarthritis 31.72 17.05 6 23353 195724 90409364
Pneumonia 31.54 17.05 74 23285 637985 89967103
Multiple organ dysfunction syndrome 31.19 17.05 60 23299 68276 90536812
Discomfort 31.00 17.05 16 23343 274319 90330769
Hypercapnia 30.79 17.05 20 23339 6657 90598431
Incorrect product administration duration 30.68 17.05 31 23328 19291 90585797
Analgesic drug level increased 30.65 17.05 15 23344 2904 90602184
Traumatic intracranial haemorrhage 30.57 17.05 10 23349 673 90604415
Cerebral haematoma 30.57 17.05 17 23342 4272 90600816
Pain in extremity 30.52 17.05 43 23316 450486 90154602
Migraine 30.50 17.05 6 23353 190386 90414702
Gastrointestinal disorder 30.48 17.05 14 23345 256673 90348415
Muscle rigidity 30.45 17.05 27 23332 14282 90590806
Cholecystitis 30.14 17.05 29 23330 17011 90588077
Tachycardia 29.86 17.05 99 23260 157574 90447514
Substance abuse 29.46 17.05 18 23341 5388 90599700
Fatigue 29.41 17.05 176 23183 1153847 89451241
Nystagmus 29.34 17.05 20 23339 7207 90597881
Bundle branch block right 29.31 17.05 18 23341 5435 90599653
Ill-defined disorder 29.26 17.05 6 23353 184885 90420203
Asthma 29.07 17.05 13 23346 242147 90362941
Apallic syndrome 29.07 17.05 10 23349 786 90604302
Product use issue 28.30 17.05 26 23333 329893 90275195
Fear of weight gain 28.28 17.05 5 23354 20 90605068
Fibromyalgia 28.22 17.05 9 23350 206260 90398828
Stomatitis 28.21 17.05 18 23341 274680 90330408
Hyperchloraemia 28.00 17.05 10 23349 878 90604210
Apathy 27.92 17.05 23 23336 11017 90594071
Hallucination 26.61 17.05 55 23304 65904 90539184
Patella fracture 26.50 17.05 13 23346 2530 90602558
Hypoosmolar state 26.37 17.05 7 23352 226 90604862
Victim of chemical submission 25.89 17.05 9 23350 730 90604358
Circulatory collapse 25.84 17.05 32 23327 24872 90580216
Dependence 25.76 17.05 12 23347 2083 90603005
Chorea 25.68 17.05 12 23347 2098 90602990
Major depression 25.57 17.05 21 23338 10014 90595074
Growth disorder 25.57 17.05 5 23354 38 90605050
Headache 25.57 17.05 125 23234 862621 89742467
Eosinophilia 25.43 17.05 34 23325 28499 90576589
Cutaneous T-cell lymphoma 25.40 17.05 11 23348 1609 90603479
Dyspepsia 24.80 17.05 10 23349 198150 90406938
Haemolytic anaemia 24.75 17.05 22 23337 11675 90593413
Electrocardiogram QRS complex shortened 24.38 17.05 8 23351 544 90604544
Acute pulmonary oedema 24.31 17.05 20 23339 9560 90595528
Antipsychotic drug level increased 24.29 17.05 14 23345 3765 90601323
Stress cardiomyopathy 24.14 17.05 23 23336 13332 90591756
Therapeutic product effect incomplete 23.92 17.05 10 23349 193886 90411202
Rash maculo-papular 23.88 17.05 40 23319 40893 90564195
Drug screen false positive 23.75 17.05 9 23350 934 90604154
Psychomotor retardation 23.70 17.05 15 23344 4774 90600314
Hyperkalaemia 23.70 17.05 52 23307 64912 90540176
Bursitis 23.68 17.05 3 23356 131651 90473437
Drug detoxification 23.47 17.05 7 23352 347 90604741
Eczema eyelids 23.40 17.05 7 23352 351 90604737
Injury 23.06 17.05 11 23348 197338 90407750
Nasal mucosal erosion 23.00 17.05 5 23354 67 90605021
Night sweats 23.00 17.05 3 23356 128763 90476325
Haemodynamic instability 22.72 17.05 21 23338 11718 90593370
Renal tubular necrosis 22.47 17.05 23 23336 14532 90590556
Cardiorenal syndrome 22.31 17.05 9 23350 1103 90603985
Orthostatic hypotension 21.94 17.05 39 23320 41788 90563300
Maternal exposure during pregnancy 21.85 17.05 37 23322 360026 90245062
Cyanosis 21.81 17.05 26 23333 19429 90585659
Avoidant personality disorder 21.78 17.05 5 23354 87 90605001
Arthritis 21.67 17.05 8 23351 167307 90437781
Torsade de pointes 21.66 17.05 23 23336 15159 90589929
Malignant catatonia 21.61 17.05 6 23353 230 90604858
Generalised tonic-clonic seizure 21.56 17.05 35 23324 34868 90570220
Tonic convulsion 21.51 17.05 10 23349 1728 90603360
Cell death 21.48 17.05 12 23347 3043 90602045
Intentional product use issue 21.21 17.05 15 23344 216877 90388211
Mucosal erosion 20.94 17.05 10 23349 1835 90603253
Inflammation 20.79 17.05 10 23349 178582 90426506
Hyperleukocytosis 20.67 17.05 8 23351 879 90604209
Aortic valve disease 20.65 17.05 9 23350 1337 90603751
Haemoglobin decreased 20.55 17.05 8 23351 161948 90443140
Platelet count decreased 20.55 17.05 5 23354 136964 90468124
Loss of personal independence in daily activities 20.36 17.05 5 23354 136100 90468988
Executive dysfunction 20.31 17.05 6 23353 288 90604800
Stevens-Johnson syndrome 20.28 17.05 31 23328 29345 90575743
White blood cell count decreased 20.01 17.05 9 23350 167100 90437988
Generalised anxiety disorder 19.89 17.05 11 23348 2736 90602352
Gastrooesophageal reflux disease 19.85 17.05 9 23350 166328 90438760
Violence-related symptom 19.72 17.05 7 23352 604 90604484
Hepatic necrosis 19.69 17.05 15 23344 6423 90598665
Cardiac output decreased 19.59 17.05 8 23351 1012 90604076
Urinary retention 19.55 17.05 35 23324 37709 90567379
Off label use 19.52 17.05 186 23173 1102066 89503022
Electric shock sensation 19.32 17.05 9 23350 1561 90603527
Hypoaesthesia 19.32 17.05 32 23327 314178 90290910
Occupational dermatitis 19.30 17.05 4 23355 42 90605046
Chronic fatigue syndrome 19.28 17.05 9 23350 1570 90603518
Dermatitis exfoliative generalised 19.27 17.05 14 23345 5579 90599509
Liver injury 19.18 17.05 10 23349 170557 90434531
Apraxia 19.01 17.05 10 23349 2252 90602836
Paraesthesia 18.89 17.05 22 23337 250304 90354784
Myoclonus 18.88 17.05 24 23335 19144 90585944
Upper respiratory tract infection 18.64 17.05 5 23354 128313 90476775
Oliguria 18.64 17.05 18 23341 10606 90594482
Shock haemorrhagic 18.27 17.05 19 23340 12226 90592862
Craniocerebral injury 18.02 17.05 11 23348 3287 90601801
Mental disability 17.90 17.05 5 23354 196 90604892
Electrolyte imbalance 17.74 17.05 26 23333 23719 90581369
Toxic encephalopathy 17.69 17.05 16 23343 8683 90596405
Oropharyngeal pain 17.69 17.05 4 23355 115183 90489905
Status epilepticus 17.60 17.05 23 23336 18851 90586237
Rash scarlatiniform 17.59 17.05 5 23354 209 90604879
Hypotonia 17.54 17.05 18 23341 11408 90593680
Neurological decompensation 17.41 17.05 11 23348 3490 90601598
Hallucination, auditory 17.34 17.05 21 23338 15954 90589134
Speech disorder 17.21 17.05 37 23322 45548 90559540
Drug dependence, antepartum 17.14 17.05 4 23355 75 90605013
Labelled drug-disease interaction issue 17.14 17.05 4 23355 75 90605013
Pulmonary embolism 17.14 17.05 73 23286 130747 90474341
Liver disorder 17.11 17.05 5 23354 121264 90483824

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug use disorder 649.23 20.18 208 14045 10125 42596957
Coma 600.57 20.18 312 13941 53242 42553840
Drug abuse 579.59 20.18 386 13867 104385 42502697
Substance use disorder 378.67 20.18 118 14135 5227 42601855
Poisoning deliberate 322.67 20.18 123 14130 10011 42597071
Toxicity to various agents 287.50 20.18 367 13886 228769 42378313
Somnolence 265.90 20.18 279 13974 140826 42466256
Mydriasis 200.97 20.18 84 14169 8686 42598396
Drug dependence 199.24 20.18 123 14130 28971 42578111
Miosis 190.47 20.18 92 14161 13354 42593728
Poisoning 179.76 20.18 91 14162 14608 42592474
Altered state of consciousness 161.47 20.18 108 14145 29151 42577931
Substance abuse 154.15 20.18 70 14183 8835 42598247
Intentional product misuse 150.74 20.18 141 14112 61759 42545323
Intentional overdose 148.52 20.18 129 14124 51327 42555755
Pneumonia aspiration 125.60 20.18 116 14137 49962 42557120
Asphyxia 121.01 20.18 58 14195 8268 42598814
Sopor 119.77 20.18 67 14186 13135 42593947
Hypothermia 96.14 20.18 57 14196 12458 42594624
Depressed level of consciousness 92.03 20.18 96 14157 47874 42559208
Bradypnoea 87.13 20.18 38 14215 4355 42602727
Agitation 86.44 20.18 107 14146 64207 42542875
Suicide attempt 84.41 20.18 90 14163 46010 42561072
Aggression 82.24 20.18 87 14166 44076 42563006
Drug ineffective 74.91 20.18 61 14192 630136 41976946
Visceral congestion 71.77 20.18 22 14231 919 42606163
Hyperthermia 65.93 20.18 45 14208 12529 42594553
Mucosal dryness 62.98 20.18 23 14230 1655 42605427
Withdrawal syndrome 55.03 20.18 43 14210 14732 42592350
Overdose 54.21 20.18 113 14140 105151 42501931
Prescription form tampering 53.96 20.18 16 14237 596 42606486
Behaviour disorder 48.68 20.18 30 14223 7024 42600058
Pneumonia 48.60 20.18 42 14211 422107 42184975
Oral discharge 47.44 20.18 11 14242 152 42606930
Screaming 45.76 20.18 19 14234 1928 42605154
Left atrial dilatation 45.11 20.18 20 14233 2382 42604700
Suicidal ideation 44.71 20.18 67 14186 48094 42558988
Haematocrit increased 43.84 20.18 20 14233 2547 42604535
Confusional state 42.63 20.18 138 14115 167459 42439623
Cluster headache 42.27 20.18 13 14240 549 42606533
Bradycardia 41.94 20.18 90 14163 85394 42521688
Intestinal atony 40.48 20.18 8 14245 48 42607034
Product dose omission issue 40.17 20.18 3 14250 154362 42452720
Housebound 38.38 20.18 10 14243 229 42606853
Bradyphrenia 37.89 20.18 23 14230 5239 42601843
Lactic acidosis 37.84 20.18 60 14193 45201 42561881
Vertigo 36.57 20.18 51 14202 34296 42572786
Gas poisoning 36.35 20.18 8 14245 86 42606996
Disturbance in attention 35.83 20.18 47 14206 29819 42577263
Nervous system disorder 35.82 20.18 36 14217 17159 42589923
Vascular stenosis 35.60 20.18 9 14244 182 42606900
Hypovolaemia 35.53 20.18 30 14223 11455 42595627
Laryngeal dyspnoea 34.81 20.18 8 14245 106 42606976
Bradykinesia 34.69 20.18 22 14231 5414 42601668
Alcohol abuse 32.55 20.18 19 14234 4030 42603052
Rhabdomyolysis 32.51 20.18 77 14176 77942 42529140
Brain oedema 31.86 20.18 33 14220 16294 42590788
Amyotrophy 31.40 20.18 10 14243 474 42606608
Hepatocellular injury 31.13 20.18 39 14214 23639 42583443
Haemoglobin increased 30.58 20.18 20 14233 5186 42601896
Loss of consciousness 30.03 20.18 83 14170 92271 42514811
Gastrointestinal necrosis 29.61 20.18 18 14235 4110 42602972
Arthralgia 29.43 20.18 16 14237 205222 42401860
Sepsis 29.38 20.18 15 14238 199319 42407763
Drug detoxification 29.17 20.18 9 14244 384 42606698
Incorrect product administration duration 28.37 20.18 20 14233 5860 42601222
Brief psychotic disorder with marked stressors 27.85 20.18 8 14245 266 42606816
Lichenoid keratosis 27.76 20.18 17 14236 3933 42603149
Pulmonary congestion 27.51 20.18 30 14223 15700 42591382
Acute kidney injury 26.81 20.18 212 14041 367125 42239957
Phlebotomy 26.43 20.18 6 14247 75 42607007
Fatigue 26.09 20.18 68 14185 435573 42171509
Hypotension 26.02 20.18 161 14092 257470 42349612
Sinus bradycardia 25.41 20.18 28 14225 14825 42592257
Parotid gland haemorrhage 25.30 20.18 5 14248 30 42607052
Victim of homicide 25.22 20.18 7 14246 205 42606877
Traumatic haemothorax 24.59 20.18 8 14245 406 42606676
Cerebrovascular stenosis 24.09 20.18 6 14247 114 42606968
White blood cell count decreased 24.07 20.18 4 14249 110392 42496690
Psychomotor skills impaired 23.49 20.18 17 14236 5187 42601895
Platelet count decreased 22.64 20.18 9 14244 138572 42468510
Victim of crime 22.44 20.18 8 14245 537 42606545
Ischaemic hepatitis 22.36 20.18 12 14241 2165 42604917
Cerebral haematoma 22.35 20.18 17 14236 5593 42601489
Wrong drug 22.08 20.18 6 14247 162 42606920
Restlessness 22.03 20.18 37 14216 29212 42577870
Abnormal behaviour 22.01 20.18 35 14218 26416 42580666
Presyncope 21.99 20.18 32 14221 22355 42584727
Anal haemorrhage 21.83 20.18 13 14240 2860 42604222
Systolic hypertension 21.76 20.18 7 14246 343 42606739
Hepatic cytolysis 21.63 20.18 35 14218 26809 42580273
Wrong patient received product 21.62 20.18 14 14239 3569 42603513
Cognitive disorder 21.57 20.18 40 14213 34132 42572950
Subdural haematoma 21.19 20.18 32 14221 23106 42583976
Psychomotor hyperactivity 21.11 20.18 22 14231 10936 42596146
Drug diversion 21.08 20.18 9 14244 978 42606104
Dyspnoea 20.87 20.18 77 14176 442544 42164538
Anxiety disorder due to a general medical condition 20.85 20.18 4 14249 20 42607062
Pancreatitis acute 20.83 20.18 39 14214 33525 42573557
Faecaloma 20.68 20.18 17 14236 6253 42600829
Motor dysfunction 20.64 20.18 19 14234 8127 42598955
Haemodynamic instability 20.33 20.18 23 14230 12534 42594548
Toxic skin eruption 20.30 20.18 24 14229 13706 42593376

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Coma 1537.64 15.76 756 35513 117113 110435917
Drug abuse 1365.28 15.76 801 35468 176610 110376420
Drug use disorder 1217.22 15.76 382 35887 17692 110535338
Poisoning deliberate 1011.96 15.76 365 35904 25966 110527064
Toxicity to various agents 719.55 15.76 834 35435 479721 110073309
Somnolence 607.53 15.76 609 35660 296840 110256190
Sopor 596.40 15.76 274 35995 36272 110516758
Substance use disorder 498.52 15.76 156 36113 7134 110545896
Intentional overdose 497.76 15.76 384 35885 132117 110420913
Miosis 384.36 15.76 173 36096 21810 110531220
Mydriasis 383.06 15.76 173 36096 21984 110531046
Suicide attempt 382.37 15.76 297 35972 103097 110449933
Altered state of consciousness 354.29 15.76 226 36043 57400 110495630
Poisoning 326.58 15.76 169 36100 28936 110524094
Drug dependence 280.01 15.76 185 36084 49835 110503195
Intentional product misuse 268.52 15.76 271 35998 132633 110420397
Bradypnoea 259.23 15.76 100 36169 8549 110544481
Hypothermia 253.46 15.76 138 36131 26164 110526866
Pneumonia aspiration 222.19 15.76 196 36073 81037 110471993
Hypotension 205.28 15.76 498 35771 523351 110029679
Overdose 203.31 15.76 312 35957 233482 110319548
Depressed level of consciousness 196.35 15.76 212 36057 112066 110440964
Substance abuse 180.17 15.76 86 36183 12377 110540653
Drug interaction 177.49 15.76 458 35811 499725 110053305
Bradycardia 169.38 15.76 231 36038 155286 110397744
Asphyxia 157.86 15.76 82 36187 14133 110538897
Agitation 154.60 15.76 188 36081 112863 110440167
Hepatocellular injury 148.13 15.76 127 36142 50515 110502515
Fall 144.27 15.76 480 35789 603002 109950028
Respiratory acidosis 134.45 15.76 73 36196 13753 110539277
Confusional state 134.23 15.76 397 35872 468283 110084747
Hyperthermia 129.59 15.76 83 36186 21189 110531841
Bradyphrenia 125.51 15.76 66 36203 11662 110541368
Suicidal ideation 121.62 15.76 152 36117 93785 110459245
Drug ineffective 118.12 15.76 199 36070 1520341 109032689
Hyponatraemia 115.57 15.76 234 36035 217419 110335611
Joint swelling 111.46 15.76 9 36260 442836 110110194
Electrocardiogram QT prolonged 106.90 15.76 154 36115 108806 110444224
Intentional self-injury 101.66 15.76 90 36179 37339 110515691
Acute kidney injury 101.00 15.76 444 35825 634986 109918044
Parkinsonism 100.36 15.76 72 36197 22115 110530915
Aggression 100.30 15.76 110 36159 59100 110493930
Abdominal discomfort 96.40 15.76 9 36260 393849 110159181
Vertigo 92.94 15.76 128 36141 86742 110466288
Peripheral swelling 91.89 15.76 12 36257 404022 110149008
Bradykinesia 88.65 15.76 51 36218 10737 110542293
Rhabdomyolysis 87.19 15.76 148 36121 120253 110432777
Withdrawal syndrome 86.31 15.76 76 36193 31304 110521726
Pain 85.55 15.76 113 36156 954842 109598188
Extrapyramidal disorder 83.60 15.76 72 36197 28795 110524235
Infusion related reaction 82.76 15.76 13 36256 381149 110171881
Psychomotor hyperactivity 80.88 15.76 61 36208 20216 110532814
Arthralgia 79.72 15.76 83 36186 779549 109773481
Hypokalaemia 79.39 15.76 181 36088 182267 110370763
Disturbance in attention 78.13 15.76 99 36170 61896 110491134
Arthropathy 77.77 15.76 4 36265 287518 110265512
Drug hypersensitivity 76.02 15.76 27 36242 454063 110098967
Loss of consciousness 75.92 15.76 186 36083 196120 110356910
Prescription form tampering 75.43 15.76 20 36249 501 110552529
Pneumonia 73.24 15.76 109 36160 876605 109676425
Housebound 72.91 15.76 19 36250 444 110552586
Toxic skin eruption 72.41 15.76 65 36204 27450 110525580
Lactic acidosis 71.08 15.76 117 36152 92694 110460336
Psychomotor skills impaired 70.67 15.76 38 36231 7020 110546010
Systemic lupus erythematosus 70.53 15.76 3 36266 254335 110298695
Rheumatoid arthritis 70.31 15.76 8 36261 299605 110253425
Product dose omission issue 69.78 15.76 11 36258 321771 110231259
Inappropriate antidiuretic hormone secretion 66.39 15.76 68 36201 33783 110519247
Sinusitis 64.66 15.76 10 36259 296678 110256352
Visceral congestion 64.46 15.76 22 36247 1323 110551707
Therapeutic product effect decreased 64.22 15.76 4 36265 244312 110308718
Alopecia 63.99 15.76 20 36249 364733 110188297
Swelling 63.86 15.76 18 36251 351023 110202007
Drug intolerance 61.78 15.76 28 36241 406484 110146546
Tremor 60.31 15.76 174 36095 202058 110350972
Disorientation 59.46 15.76 93 36176 70578 110482452
Hypoglycaemia 59.40 15.76 123 36146 115981 110437049
Alcohol abuse 59.26 15.76 30 36239 4899 110548131
Sinus bradycardia 59.23 15.76 60 36209 29423 110523607
Respiratory depression 58.66 15.76 62 36207 31939 110521091
Metabolic acidosis 58.64 15.76 112 36157 99632 110453398
Lower respiratory tract infection 58.28 15.76 6 36263 243100 110309930
Mucosal dryness 57.33 15.76 28 36241 4235 110548795
Incorrect product administration duration 55.08 15.76 49 36220 20449 110532581
Cor pulmonale acute 55.04 15.76 17 36252 743 110552287
Arrhythmia 55.02 15.76 89 36180 69486 110483544
Wheezing 54.71 15.76 9 36260 255221 110297809
Pericarditis 53.60 15.76 5 36264 219109 110333921
Hepatic cytolysis 52.78 15.76 77 36192 54976 110498054
Rash 52.58 15.76 120 36149 820844 109732186
Persecutory delusion 52.38 15.76 30 36239 6261 110546769
Psoriatic arthropathy 52.38 15.76 3 36266 196758 110356272
Nasopharyngitis 51.39 15.76 33 36236 394328 110158702
Toxic epidermal necrolysis 51.02 15.76 77 36192 56650 110496380
Pain in extremity 50.69 15.76 51 36218 487067 110065963
Hepatic enzyme increased 50.49 15.76 21 36248 320871 110232159
Accidental death 50.24 15.76 27 36242 4982 110548048
Behaviour disorder 49.91 15.76 34 36235 9613 110543417
Treatment failure 48.97 15.76 15 36254 277219 110275811
Hepatitis acute 48.72 15.76 44 36225 18722 110534308
Fatigue 48.38 15.76 220 36049 1215738 109337292
Cerebral haematoma 47.60 15.76 33 36236 9599 110543431
Hypersensitivity 47.16 15.76 38 36231 403960 110149070
Infection 46.25 15.76 31 36238 362169 110190861
Asthma 45.20 15.76 13 36256 250278 110302752
Livedo reticularis 45.16 15.76 26 36243 5480 110547550
White blood cell count decreased 45.11 15.76 10 36259 229380 110323650
Amyotrophy 43.82 15.76 14 36255 684 110552346
Mobility decreased 43.48 15.76 12 36257 237410 110315620
Blood cholesterol increased 43.17 15.76 5 36264 184780 110368250
Wound 42.66 15.76 12 36257 234425 110318605
Tachycardia 42.63 15.76 167 36102 226478 110326552
Irritable bowel syndrome 42.23 15.76 3 36266 164212 110388818
Platelet count decreased 41.55 15.76 12 36257 230431 110322599
Oral discharge 41.51 15.76 11 36258 275 110552755
Pulmonary congestion 41.48 15.76 51 36218 30915 110522115
Haemodynamic instability 41.34 15.76 44 36225 22844 110530186
Wrong rate 41.22 15.76 10 36259 173 110552857
Gastrointestinal disorder 41.12 15.76 14 36255 241938 110311092
Bezoar 41.07 15.76 22 36247 4032 110548998
Drug reaction with eosinophilia and systemic symptoms 40.85 15.76 86 36183 82009 110471021
Dermatitis exfoliative 40.59 15.76 32 36237 11315 110541715
Folliculitis 40.54 15.76 4 36265 167649 110385381
Ill-defined disorder 39.95 15.76 3 36266 156850 110396180
Impaired healing 39.86 15.76 8 36261 196709 110356321
Gastrooesophageal reflux disease 39.35 15.76 6 36263 179970 110373060
Hypercapnic coma 39.33 15.76 12 36257 503 110552527
Electrocardiogram QRS complex prolonged 38.76 15.76 33 36236 12988 110540042
Musculoskeletal stiffness 38.42 15.76 22 36247 279800 110273230
Left atrial dilatation 37.99 15.76 20 36249 3540 110549490
Dyspnoea 37.85 15.76 211 36058 1106661 109446369
Cholestasis 37.37 15.76 72 36197 64446 110488584
Contusion 37.14 15.76 15 36254 233346 110319684
Sinoatrial block 37.10 15.76 15 36254 1450 110551580
Haemoglobin decreased 36.43 15.76 18 36251 248709 110304321
Cluster headache 36.32 15.76 14 36255 1193 110551837
Contraindicated product administered 36.31 15.76 18 36251 248249 110304781
Gas poisoning 36.25 15.76 8 36261 89 110552941
Salivary hypersecretion 35.99 15.76 36 36233 17385 110535645
Osteoarthritis 35.83 15.76 8 36261 182615 110370415
Hepatitis toxic 35.80 15.76 23 36246 5898 110547132
Tonic convulsion 34.89 15.76 18 36251 3056 110549974
Therapeutic product effect incomplete 34.63 15.76 15 36254 223790 110329240
Fibromyalgia 34.52 15.76 7 36262 170902 110382128
Meningioma 34.24 15.76 22 36247 5643 110547387
Headache 34.21 15.76 161 36108 882216 109670814
Coma scale abnormal 33.87 15.76 27 36242 9699 110543331
Cardiac failure congestive 33.09 15.76 5 36264 150995 110402035
Serotonin syndrome 33.02 15.76 65 36204 59088 110493942
Night sweats 32.91 15.76 3 36266 133980 110419050
Nervous system disorder 32.80 15.76 46 36223 31675 110521355
Apraxia 32.51 15.76 18 36251 3522 110549508
Orthostatic hypotension 32.49 15.76 69 36200 66180 110486850
Screaming 32.11 15.76 20 36249 4861 110548169
Brain oedema 32.01 15.76 45 36224 31053 110521977
Product use issue 31.98 15.76 33 36236 311662 110241368
Haematocrit increased 31.82 15.76 20 36249 4939 110548091
Off label use 31.80 15.76 327 35942 1499858 109053172
Cognitive disorder 31.78 15.76 81 36188 87430 110465600
Arthritis 31.58 15.76 8 36261 167578 110385452
Victim of crime 31.08 15.76 13 36256 1370 110551660
Abnormal behaviour 30.94 15.76 50 36219 38989 110514041
Migraine 30.83 15.76 9 36260 171643 110381387
Traumatic haemothorax 30.74 15.76 11 36258 761 110552269
Prevertebral soft tissue swelling of cervical space 30.47 15.76 6 36263 36 110552994
Restlessness 30.42 15.76 61 36208 56198 110496832
Vasoplegia syndrome 30.13 15.76 20 36249 5419 110547611
Labelled drug-drug interaction issue 30.04 15.76 18 36251 4083 110548947
Nystagmus 29.77 15.76 27 36242 11550 110541480
Thymus disorder 29.71 15.76 10 36259 576 110552454
Drug detoxification 29.68 15.76 10 36259 578 110552452
Victim of chemical submission 29.35 15.76 11 36258 868 110552162
Bursitis 29.17 15.76 4 36265 129914 110423116
Intestinal atony 29.08 15.76 8 36261 231 110552799
Postmortem blood drug level abnormal 28.85 15.76 10 36259 630 110552400
Oropharyngeal pain 28.47 15.76 5 36264 135271 110417759
Hypoaesthesia 28.21 15.76 37 36232 314186 110238844
Cholinergic syndrome 28.20 15.76 12 36257 1320 110551710
Dependence 28.18 15.76 15 36254 2714 110550316
Drug diversion 27.79 15.76 12 36257 1368 110551662
Fear of weight gain 27.28 15.76 5 36264 19 110553011
Status epilepticus 27.18 15.76 42 36227 31529 110521501
Patella fracture 26.95 15.76 14 36255 2412 110550618
Hospitalisation 26.46 15.76 7 36262 142486 110410544
Pancreatitis acute 26.41 15.76 60 36209 60214 110492816
Purpura 26.16 15.76 36 36233 24352 110528678
Cardiogenic shock 26.15 15.76 58 36211 57280 110495750
Pyramidal tract syndrome 26.11 15.76 10 36259 837 110552193
Laryngeal dyspnoea 25.94 15.76 8 36261 348 110552682
Brief psychotic disorder with marked stressors 25.85 15.76 8 36261 352 110552678
Phlebotomy 25.79 15.76 6 36263 86 110552944
Toxic encephalopathy 25.29 15.76 28 36241 15186 110537844
Adverse event 25.27 15.76 3 36266 108806 110444224
Parotid gland haemorrhage 25.26 15.76 5 36264 31 110552999
Nausea 25.05 15.76 272 35997 1235418 109317612
Maternal exposure during pregnancy 25.01 15.76 28 36241 254855 110298175
Drug level increased 24.92 15.76 51 36218 47668 110505362
Dyspepsia 24.83 15.76 16 36253 190949 110362081
Anal haemorrhage 24.55 15.76 17 36252 4935 110548095
Hypotonia 24.51 15.76 28 36241 15717 110537313
Injection site pain 24.40 15.76 14 36255 177908 110375122
Wrong patient received product 24.25 15.76 19 36250 6655 110546375
Subdural haematoma 24.01 15.76 43 36226 36411 110516619
Substance dependence 23.94 15.76 9 36260 716 110552314
Ventricular dyskinesia 23.94 15.76 8 36261 451 110552579
Hyperthyroidism 23.90 15.76 38 36231 29223 110523807
Victim of homicide 23.86 15.76 7 36262 256 110552774
Urinary retention 23.76 15.76 63 36206 69620 110483410
Wrong patient 23.68 15.76 11 36258 1488 110551542
Apallic syndrome 23.53 15.76 10 36259 1096 110551934
Vascular stenosis 23.32 15.76 9 36260 769 110552261
Agranulocytosis 23.29 15.76 58 36211 61702 110491328
Loss of personal independence in daily activities 23.29 15.76 10 36259 150010 110403020
Rash maculo-papular 23.21 15.76 65 36204 74157 110478873
Analgesic drug level increased 23.05 15.76 15 36254 3931 110549099
Acute pulmonary oedema 22.78 15.76 28 36241 16968 110536062
Occupational exposure to product 22.67 15.76 9 36260 830 110552200
Delusion 22.44 15.76 33 36236 23722 110529308
Sepsis 22.42 15.76 46 36223 327300 110225730
Gastrointestinal necrosis 22.20 15.76 18 36251 6622 110546408
Autoimmune haemolytic anaemia 22.13 15.76 22 36247 10545 110542485
Cyanosis 22.09 15.76 37 36232 29704 110523326
Cerebrovascular stenosis 21.99 15.76 6 36263 168 110552862
Hyperchloraemia 21.93 15.76 10 36259 1296 110551734
Nasal mucosal erosion 21.80 15.76 5 36264 67 110552963
Presyncope 21.79 15.76 49 36220 48838 110504192
Hypovolaemia 21.77 15.76 31 36238 21643 110531387
Discomfort 21.71 15.76 23 36246 214684 110338346
Blood creatinine increased 21.57 15.76 17 36252 182872 110370158
Phlebitis 21.56 15.76 21 36248 9820 110543210
Cough 21.09 15.76 79 36190 461562 110091468
Haemoglobin increased 20.95 15.76 20 36249 9127 110543903
Hallucination 20.92 15.76 77 36192 101355 110451675
Traumatic intracranial haemorrhage 20.77 15.76 10 36259 1466 110551564
Prescription drug used without a prescription 20.74 15.76 16 36253 5480 110547550
Hypoosmolar state 20.65 15.76 7 36262 412 110552618
Cross sensitivity reaction 20.56 15.76 16 36253 5551 110547479
Eczema eyelids 20.52 15.76 7 36262 420 110552610
Anxiety disorder due to a general medical condition 20.46 15.76 4 36265 23 110553007
Sciatica 20.38 15.76 3 36266 92396 110460634
Sinus tachycardia 20.28 15.76 45 36224 44448 110508582
Generalised tonic-clonic seizure 20.25 15.76 51 36218 54629 110498401
Stomatitis 20.23 15.76 36 36233 270206 110282824
Major depression 20.22 15.76 21 36248 10600 110542430
Avoidant personality disorder 20.02 15.76 5 36264 98 110552932
COVID-19 treatment 19.97 15.76 7 36262 456 110552574
Hallucination, auditory 19.82 15.76 33 36236 26364 110526666
Myoglobin blood increased 19.75 15.76 14 36255 4218 110548812
Psychomotor retardation 19.70 15.76 18 36251 7774 110545256
Neurological decompensation 19.58 15.76 17 36252 6866 110546164
Electrocardiogram QRS complex shortened 19.41 15.76 8 36261 812 110552218
Hypercapnia 19.35 15.76 21 36248 11138 110541892
Liver function test increased 19.24 15.76 3 36266 88545 110464485
Growth disorder 19.18 15.76 5 36264 117 110552913
Hypertensive crisis 19.02 15.76 31 36238 24341 110528689
Apathy 18.99 15.76 25 36244 16214 110536816
Neutrophil count decreased 18.87 15.76 8 36261 120933 110432097
Lichenoid keratosis 18.82 15.76 16 36253 6286 110546744
Injection site erythema 18.72 15.76 4 36265 94172 110458858
Back pain 18.61 15.76 61 36208 370935 110182095
Drug screen false positive 18.43 15.76 9 36260 1360 110551670
Eosinophilia 18.37 15.76 51 36218 57885 110495145
Gait inability 18.31 15.76 11 36258 136365 110416665
Haemolytic anaemia 18.25 15.76 28 36241 20892 110532138
C-reactive protein increased 18.21 15.76 27 36242 217892 110335138
Chorea 18.17 15.76 12 36257 3223 110549807
Systolic hypertension 18.17 15.76 8 36261 956 110552074
Chronic fatigue syndrome 18.07 15.76 9 36260 1420 110551610
Acute respiratory distress syndrome 18.04 15.76 48 36221 53150 110499880
Psychiatric decompensation 17.96 15.76 15 36254 5750 110547280
Conjunctival hyperaemia 17.81 15.76 15 36254 5816 110547214
Bundle branch block right 17.70 15.76 21 36248 12270 110540760
Condition aggravated 17.69 15.76 155 36114 734681 109818349
Leukocytosis 17.68 15.76 48 36221 53780 110499250
Craniocerebral injury 17.58 15.76 15 36254 5919 110547111
Rash scarlatiniform 17.56 15.76 6 36263 362 110552668
Urinary tract infection 17.52 15.76 52 36217 326230 110226800
Generalised anxiety disorder 17.31 15.76 11 36258 2768 110550262
Anaphylactic reaction 17.14 15.76 8 36261 114292 110438738
Upper respiratory tract infection 17.07 15.76 11 36258 131317 110421713
Dry skin 16.99 15.76 7 36262 107646 110445384
Ischaemic stroke 16.89 15.76 40 36229 41223 110511807
Shock 16.82 15.76 47 36222 53541 110499489
Executive dysfunction 16.71 15.76 6 36263 419 110552611
Muscle rigidity 16.67 15.76 29 36240 24002 110529028
Learning disorder 16.67 15.76 7 36262 745 110552285
Dysarthria 16.63 15.76 63 36206 84058 110468972
Bronchospasm 16.60 15.76 33 36236 30206 110522824
Respiratory distress 16.55 15.76 55 36214 68819 110484211
Psoriasis 16.52 15.76 13 36256 139980 110413050
Hyperkalaemia 16.49 15.76 88 36181 135708 110417322
Stress cardiomyopathy 16.46 15.76 23 36246 15783 110537247
Stress 16.39 15.76 7 36262 105341 110447689
Cholecystitis 16.37 15.76 30 36239 25852 110527178
Wrong drug 16.37 15.76 6 36263 445 110552585
Sudden death 16.35 15.76 29 36240 24366 110528664
Abdominal distension 16.35 15.76 20 36249 175083 110377947
Mental disability 15.92 15.76 5 36264 231 110552799
Cellulitis 15.78 15.76 11 36258 126005 110427025

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N05BA08 NERVOUS SYSTEM
PSYCHOLEPTICS
ANXIOLYTICS
Benzodiazepine derivatives
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D011619 Psychotropic Drugs
MeSH PA D014151 Anti-Anxiety Agents
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018682 GABA Agents
MeSH PA D018757 GABA Modulators
CHEBI has role CHEBI:35469 antidepressant
CHEBI has role CHEBI:35474 anxiolytic drug
CHEBI has role CHEBI:35476 antipsychotic agent

Related Drugs by ATC class:

N05BA Benzodiazepine derivatives 23 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.29 acidic
pKa2 3.26 Basic
pKa3 2.58 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
GABA-A receptor alpha-1/beta-2/gamma-2 Ion channel WOMBAT-PK

External reference:

IDSource
N0000166922 NUI
D01245 KEGG_DRUG
1749 RXNORM
C0006213 UMLSCUI
CHEBI:31302 CHEBI
CHEMBL277062 ChEMBL_ID
DB01558 DRUGBANK_ID
D001960 MESH_DESCRIPTOR_UI
2441 PUBCHEM_CID
2692 INN_ID
X015L14V0O UNII
11834 MMSL
387571009 SNOMEDCT_US
96234002 SNOMEDCT_US
003512 NDDF

Pharmaceutical products:

None